Understanding your child's genetic susceptibilities allows you to implement targeted prevention strategies before problems develop or worsen
This means if you weigh 200 pounds at the start of treatment, you can expect to lose around 30 pounds in about a years time
TIRZEPATIDE, a dual GIP and GLP-1 receptor agonist already widely used in Type 2 diabetes and obesity management, is gaining interest for use in people with Type 1 diabetes (T1D) who also have obesity
Current evidence suggests tirzepatide helps improve testosterone levels in obese men
SIM1, BDNF , and NTRK2 are necessary for the development of the hypothalamus, and mutations in any of these can lead to hyperphagia and severe obesity [3742]
Kllstig E, McCabe BD, Schneider BL